Ownership and insider activity for Cosmos Health Inc. (COSM): insider transactions, US Senate and House trading disclosures and shares outstanding. Track how corporate insiders and politicians are trading the stock.
Cosmos Health Inc. functions as a vertically integrated pharmaceutical firm, providing its own line of branded and generic medicines, nutraceuticals, non-prescription drugs, healthcare and infant products, medical devices, and various other goods. These are distributed via its established channels and an e-commerce marketplace. The company actively seeks, obtains, develops, and commercializes solutions designed to improve patients' well-being and health outcomes.
Price
| Price | $0.27 |
| Market Cap | $15M |
| Exchange | NASDAQ |
| Country | GR |
Recent Insider Transactions
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 2026-07-30 | Siokas Grigorios | P-Purchase | 349,825 | $70K |
| 2026-07-29 | Terzis Georgios | A-Award | 328,407 | $60K |
| 2026-07-29 | Siokas Grigorios | P-Purchase | 766,284 | $140K |
| 2026-06-16 | Terzis Georgios | P-Purchase | 168,135 | $42K |
| 2026-06-11 | Siokas Grigorios | P-Purchase | 218,447 | $45K |
| 2026-06-10 | Siokas Grigorios | P-Purchase | 701,447 | $160K |
| 2026-05-19 | Karkantzos Theodoros Christos | A-Award | 20,000 | $6K |
| 2026-05-19 | Karkantzos Theodoros Christos | C-Conversion | 35,000 | |
| 2026-05-19 | Hoidas John James | A-Award | 20,000 | $6K |
| 2026-05-19 | Hoidas John James | C-Conversion | 20,000 |
Balance Sheet (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $716590 | $782853 | $864343 | $38537 | $628395 | $286487 | $20.7M | $3.8M | $315105 | $715674 |
| Short-term Investments | 0 | 0 | $2.7M | $238940 | $222792 | $11468 | $14881 | $20075 | $21148 | $46158 |
| Receivables | $793750 | $1.4M | $4.9M | $9.3M | $26.9M | $30.1M | $22.8M | $21.7M | $15.9M | $22.6M |
| Inventory | $464219 | $3.1M | $3.2M | $3.5M | $3.3M | $3.1M | $3.5M | $4.8M | $4.4M | $5.8M |
| Total Current Assets | $2.6M | $9.5M | $18.3M | $21.2M | $40.8M | $39.8M | $56.0M | $36.6M | $25.5M | $38.4M |
| Property, Plant & Equipment | $52715 | $114567 | $1.4M | $1.7M | $1.8M | $2.9M | $2.9M | $11.6M | $10.4M | $11.8M |
| Goodwill | 0 | 0 | $49697 | $49697 | $49697 | $49698 | $49697 | $49697 | $49697 | $49697 |
| Intangible Assets | 0 | $41994 | $247070 | $213984 | $180809 | $436069 | $657217 | $7.6M | $7.7M | $7.5M |
| Total Assets | $3.1M | $10.7M | $20.7M | $23.9M | $43.8M | $49.4M | $68.0M | $66.0M | $54.3M | $65.5M |
| Accounts Payable | $591691 | $2.2M | $5.9M | $8.0M | $12.0M | $12.1M | $10.3M | $11.9M | $11.2M | $14.6M |
| Short-term Debt | $3.2M | $10.2M | $15.0M | $18.7M | $19.7M | $13.3M | $8.0M | $8.2M | $9.6M | $13.5M |
| Total Current Liabilities | $4.9M | $13.7M | $22.3M | $28.2M | $34.3M | $29.9M | $21.7M | $24.3M | $25.8M | $38.3M |
| Long-term Debt | 0 | 0 | $1.6M | 0 | $11.3M | $12.7M | $2.9M | $3.0M | $1.6M | $5.9M |
| Total Liabilities | $4.9M | $13.7M | $24.0M | $30.3M | $48.0M | $45.0M | $28.4M | $30.0M | $29.8M | $47.1M |
| Retained Earnings | -$1.0M | -$7.2M | -$16.3M | -$19.6M | -$18.8M | -$34.3M | -$66.2M | -$91.6M | -$114.0M | -$133.2M |
| Total Equity | -$1.8M | -$3.0M | -$3.3M | -$6.5M | -$4.2M | $4.4M | $39.7M | $36.0M | $24.5M | $18.4M |
| Total Debt | $3.2M | $10.2M | $16.6M | $19.3M | $32.0M | $27.1M | $12.0M | $12.4M | $11.8M | $20.0M |
| Net Debt | $2.5M | $9.4M | $13.0M | $19.0M | $31.2M | $26.8M | -$8.7M | $8.6M | $11.5M | $19.2M |
| Working Capital | -$2.2M | -$4.2M | -$3.9M | -$7.1M | $6.5M | $9.9M | $34.3M | $12.3M | -$296193 | $116412 |
Financial Health
| Debt / Equity | 1.08 |
| Current Ratio | 1.00 |
| Piotroski F-Score | 4 |
| Altman Z-Score | -2.49 |
Profitability
| Return on Equity | -103.91% |
| Return on Invested Capital | -40.39% |
| Return on Assets | -29.24% |
| Gross Margin | 12.10% |
| Operating Margin | -25.34% |
| Net Margin | -29.33% |
Related companies: CASI · CLSD · FEMY · IINN · LSTA · MTVA · NCNA
Explore sector: Healthcare · Medical - Pharmaceuticals
More sections of COSM: Overview · Financials · Valuation · Statistics · Estimates · Technical · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks